U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264062) titled 'MetSense Pilot and Feasibility' on Nov. 24.
Brief Summary: People with serious mental illness have high risk for type 2 diabetes due to multiple risk factors, including the metabolic side effects of psychotropic medications that are used to treat these conditions. Type 2 diabetes is preventable through lifestyle and pharmacological interventions, but many people with serious mental illness do not receive regular screening for type 2 diabetes risk. In many health care settings, clinical pharmacists are increasingly managing patients with serious mental illness and have expertise in monitoring the metabolic side effects of psychotropic...